ITRACONAZOLE

FUNGIVICE

COMPOSITON
ITRACONAZOLE100MG /200MG
SPECIFICATION
FORMCAPSULECAPSULE
PACKING10X410X1X4
PACKING TYPECAPSULECAPSULE
MRP750 | 10001250

DESCRIPTION

One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis. [PubChem]

SIDE EFFECTS

For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis.

INDICATION

Important Notice:-  The Database is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.